Safety assessment of the indigenous probiotic strain Lactiplantibacillus plantarum subsp. plantarum Kita-3 using Sprague–Dawley rats as a model
- 2022
- AIMS Microbiology 8(4)
- Moh. A'inurrofiqin
- E. Rahayu
- D. Suroto
- Tyas Utami
- Yunika Mayangsari
- PubMed: 36694579
- DOI: 10.3934/microbiol.2022028
Abstract
Lactiplantibacillus plantarum subsp. plantarum Kita-3 is a candidate probiotic from Halloumi cheese produced by Mazaraat Artisan Cheese, Yogyakarta, Indonesia. This study evaluated the safety of consuming a high dose of L. plantarum subsp. plantarum Kita-3 in Sprague-Dawley rats for 28 days. Eighteen male rats were randomly divided into three groups, such as the control group, the skim milk group, and the probiotic group. Feed intake and body weight were monitored, and blood samples, organs (kidneys, spleen, and liver), and the colon were dissected. Organ weight, hematological parameters, serum glutamic oxaloacetic transaminase (SGOT), and serum glutamic pyruvic transaminase (SGPT) concentrations, as well as intestinal morphology of the rats, were measured. Microbial analyses were carried out on the digesta, feces, blood, organs, and colon. The results showed that consumption of L. plantarum did not negatively affect general health, organ weight, hematological parameters, SGOT and SGPT activities, or intestinal morphology. The number of L. plantarum in the feces of rats increased significantly, indicating survival of the bacterium in the gastrointestinal tract. The bacteria in the blood, organs, and colon of all groups were identified using repetitive-polymerase chain reaction with the BOXA1R primers and further by 16S rRNA gene sequencing analysis, which revealed that they were not identical to L. plantarum subsp. plantarum Kita-3. Thus, this strain did not translocate to the blood or organs of rats. Therefore, L. plantarum subsp. plantarum Kita-3 is likely to be safe for human consumption.
Keywords: Lactiplantibacillus plantarum; bacterial translocation; probiotic; safety assessment.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactiplantibacillus plantarum | Increased Gut Lactobacillus plantarum Population | Neutral | Moderate |
Lactiplantibacillus plantarum | Maintained General Health | Neutral | Moderate |
Lactiplantibacillus plantarum | Reduced Bacterial Translocation | Neutral | Large |
Lactiplantibacillus plantarum KABP™-022 | Increased Survival in Gastrointestinal Tract | Beneficial | Moderate |
Lactiplantibacillus plantarum KABP™-022 | Maintained General Health | Neutral | Moderate |
Lactiplantibacillus plantarum KABP™-022 | Non-Translocation to Blood or Organs | Beneficial | Moderate |
Lactiplantibacillus plantarum KABP™-023 | Enhanced Probiotic Survival in Gastrointestinal Tract | Neutral | Moderate |
Lactiplantibacillus plantarum KABP™-023 | Maintained General Health | Neutral | Moderate |
Lactiplantibacillus plantarum KABP™-023 | Non-Translocation to Blood or Organs | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-01 | Enhanced Food Safety | Neutral | Large |
Lactiplantibacillus plantarum LP-01 | Increased Bacterial Survival | Neutral | Moderate |
Lactiplantibacillus plantarum LP-01 | Increased Bacterial Translocation | Neutral | Large |
Lactiplantibacillus plantarum LP-1 | Enhanced Probiotic Survival in Gastrointestinal Tract | Neutral | Moderate |
Lactiplantibacillus plantarum LP-1 | Maintained General Health | Neutral | Moderate |
Lactiplantibacillus plantarum LP-1 | Maintained Morphological Integrity | Neutral | Moderate |
Lactiplantibacillus plantarum LP-1 | No Negative Impact on Hematological Parameters | Neutral | Moderate |
Lactiplantibacillus plantarum LP-1 | Non-Translocation to Blood or Organs | Beneficial | Moderate |
Lactiplantibacillus plantarum LP-1 | Stable Organ Weight | Neutral | Moderate |
Lactiplantibacillus plantarum Lp-115 | Increased Survival in Gastrointestinal Tract | Beneficial | Moderate |
Lactiplantibacillus plantarum Lp-115 | Maintained General Health | Neutral | Moderate |